School of Pharmacology, Zhejiang Chinese Medical University, Hangzhou, Zhejiang Province, PR China.
Drug Chem Toxicol. 2020 Nov;43(6):574-580. doi: 10.1080/01480545.2018.1524474. Epub 2018 Nov 28.
Acyclovir (ACV) is a nucleoside antivirus-free agent that was developed and marketed by Burroughs Well-come of the United States. Renal damage from ACV has been a major factor limiting its clinical application. Thus, the renal toxicity mechanism of ACV requires systematic study. In our previous study, we speculated that the nephrotoxicity of ACV may be associated with oxidative stress. In addition to the study of ACV's toxic effect , it is also necessary to explore the absorption and distribution of ACV in the body to further investigate the changes to ACV in the body. In this study, the toxicokinetics ACV in the kidney of the rat were explored using microdialysis, and the renal function of rats was measured. The results showed that high-dose ACV is associated with renal toxicity after a single intravenous injection or successive administration.
阿昔洛韦(ACV)是一种美国伯勒斯惠康公司开发和销售的核苷类抗病毒非处方药。ACV 对肾脏的损害一直是限制其临床应用的主要因素。因此,ACV 的肾毒性机制需要系统研究。在我们之前的研究中,我们推测 ACV 的肾毒性可能与氧化应激有关。除了研究 ACV 的毒性作用外,还需要探讨 ACV 在体内的吸收和分布,以进一步研究体内 ACV 的变化。在这项研究中,采用微透析法研究了大鼠肾脏中 ACV 的毒代动力学,并测量了大鼠的肾功能。结果表明,单次静脉注射或连续给药后,高剂量 ACV 与肾毒性有关。